Cancer cells | Effector: Targeta | NK cytolysis (%)b | pc | |
Control (Not pre-treated) | Pre-treated by 10 µg/ml Anti-HLA-G | |||
MCF-7 | 10:1 | 80.3 ± 10.5 (12) | 89.8 ± 8.5 (12) | <0.05 |
5:1 | 72.9 ± 11.3 (12) | 82.0 ± 8.9 (12) | <0.05 | |
2.5:1 | 50.2 ± 10.4 (12) | 60.4 ± 11.9 (12) | <0.05 | |
T47D | 10:1 | 86.3 ± 8.5 (12) | 90.1 ± 2.3 (12) | NS d |
5:1 | 79.2 ± 5.9 (12) | 85.7 ± 7.7 (12) | <0.05 | |
2.5:1 | 68.1 ± 4.4 (12) | 76.3 ± 2.7 (12) | <0.01 | |
MDA-MB-231 | 10:1 | 47.7 ± 14.3 (12) | 60.3 ± 13.7 (12) | <0.05 |
5:1 | 31.9 ± 11.3 (12) | 42.6 ± 12.5 (12) | <0.05 | |
2.5:1 | 15.1 ± 11.8 (12) | 26.8 ± 12.0 (12) | <0.05 |